NovaBay Pharma raises $20 mln in IPO at $4 per share
NEW YORK, Oct 25 (Reuters) - NovaBay Pharmaceuticals Inc. (NBY.TO: Quote, Profile, Research, Stock Buzz) (NBY.A: Quote, Profile, Research, Stock Buzz) on Thursday said it raised $20 million in an initial public offering priced at the bottom end of an earlier projected range.
Emeryville, California-based NovaBay said it priced its offering at $4 per share and sold 5 million shares. The original projected range was $4 to $6 per share. Its shares will trade on the American Stock Exchange and possibly on the Toronto Stock Exchange, the company said.
Dundee Securities Corp is acting as the sole bookrunner for the offering.
The company is focused on developing better drugs to treat hospital-borne infections and other conditions.
© Thomson Reuters 2008 All rights reserved
Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.
Have a correction to this article? Email the editors
Tighter race?
Asia greets G7 weekend pledges